APPL1 regulates basal NF-kB activity by stabilizing NIK

Journal of Cell Science

Volumn 125, Issue 17, 2012, Pages 4090-4102

  Hupalowska, Anna ^a   Pyrzynska, Beata ^a   Miaczynska, Marta ^a  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

APPL1; NF kB pathway; NIK; TRAF2

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN PLECKSTRIN PHOSPHOTYROSINE LEUCINE ZIPPER MOTIF 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPA B INDUCING KINASE; PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL NUCLEUS; ENDOSOMES; ENZYME STABILITY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NF-KAPPA B; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTOR RELA;

EID: 84869099031     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.105171     Document Type: Article

References (59)

1. Ajuwon, K. M. and Spurlock, M. E. (2005). Adiponectin inhibits LPS-induced NFkappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-R1225.
2. Au, P. Y. and Yeh, W. C. (2007). Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv. Exp. Med. Biol. 597, 32-47.
3. Banach-Orlowska, M., Pilecka, I., Torun, A., Pyrzynska, B. and Miaczynska, M. (2009). Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex. Biochem. J. 423, 389-400.
4. Borlido, J., Zecchini, V. and Mills, I. G. (2009). Nuclear trafficking and functions of endocytic proteins implicated in oncogenesis. Traffic 10, 1209-1220.
5. Brissoni, B., Agostini, L., Kropf, M., Martinon, F., Swoboda, V., Lippens, S., Everett, H., Aebi, N., Janssens, S., Meylan, E. et al. (2006). Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr. Biol. 16, 2265-2270.
6. Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J. and Volpe, F. (2000). Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2, 346-351.
7. Chandrasekar, B., Boylston, W. H., Venkatachalam, K., Webster, N. J., Prabhu, S. D. and Valente, A. J. (2008). Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. J. Biol. Chem. 283, 24889-24898.
8. Cheng, K. K., Iglesias, M. A., Lam, K. S., Wang, Y., Sweeney, G., Zhu, W., Vanhoutte, P. M., Kraegen, E. W. and Xu, A. (2009). APPL1 potentiates insulinmediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 9, 417-427.
9. Chung, J. Y., Lu, M., Yin, Q. and Wu, H. (2007). Structural revelations of TRAF2 function in TNF receptor signaling pathway. Adv. Exp. Med. Biol. 597, 93-113.
10. Deepa, S. S. and Dong, L. Q. (2009). APPL1: role in adiponectin signaling and beyond. Am. J. Physiol. Endocrinol. Metab. 296, E22-E36.
11. Erdmann, K. S., Mao, Y., McCrea, H. J., Zoncu, R., Lee, S., Paradise, S., Modregger, J., Biemesderfer, D., Toomre, D. and De Camilli, P. (2007). A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev. Cell 13, 377-390.
12. Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B. and Pei, G. (2004). Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14, 303-317.
13. Ghosh, S. and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl., S81-S96.
14. Grech, A. P., Amesbury, M., Chan, T., Gardam, S., Basten, A. and Brink, R. (2004). TRAF2 differentially regulates the canonical and noncanonical pathways of NFkappaB activation in mature B cells. Immunity 21, 629-642.
15. Habelhah, H., Takahashi, S., Cho, S. G., Kadoya, T., Watanabe, T. and Ronai, Z. (2004). Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J. 23, 322-332.
16. Hattori, Y., Hattori, S., Akimoto, K., Nishikimi, T., Suzuki, K., Matsuoka, H. and Kasai, K. (2007). Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes 56, 804-808.
17. Hayden, M. S. and Ghosh, S. (2004). Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
18. Hayden, M. S. and Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell 132, 344-362.
19. Heilbronn, L. K. and Campbell, L. V. (2008). Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des. 14, 1225-1230.
20. Hoffmann, A. and Baltimore, D. (2006). Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210, 171-186.
21. Kittler, R., Heninger, A. K., Franke, K., Habermann, B. and Buchholz, F. (2005). Production of endoribonuclease-prepared short interfering RNAs for gene silencing in mammalian cells. Nat. Methods 2, 779-784.
22. Liao, G., Zhang, M., Harhaj, E. W. and Sun, S. C. (2004). Regulation of the NFkappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250.
23. Madge, L. A., Kluger, M. S., Orange, J. S. and May, M. J. (2008). Lymphotoxinalpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. J. Immunol. 180, 3467-3477.
24. Malinin, N. L., Boldin, M. P., Kovalenko, A. V. and Wallach, D. (1997). MAP3Krelated kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
25. Mao, X., Kikani, C. K., Riojas, R. A., Langlais, P., Wang, L., Ramos, F. J., Fang, Q., Christ-Roberts, C. Y., Hong, J. Y., Kim, R. Y. et al. (2006). APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 8, 516-523.
26. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A. et al. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866.
27. Miaczynska, M., Christoforidis, S., Giner, A., Shevchenko, A., Uttenweiler-Joseph, S., Habermann, B., Wilm, M., Parton, R. G. and Zerial, M. (2004). APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116, 445-456.
28. Mitsuuchi, Y., Johnson, S. W., Sonoda, G., Tanno, S., Golemis, E. A. and Testa, J. R. (1999). Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 18, 4891-4898.
29. Naudé, P. J., den Boer, J. A., Luiten, P. G. and Eisel, U. L. (2011). Tumor necrosis factor receptor cross-talk. FEBS J. 278, 888-898.
30. Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M. et al. (2000). Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102, 1296-1301.
31. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M. and Donner, D. B. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serinethreonine kinase. Nature 401, 82-85.
32. Pomerantz, J. L. and Baltimore, D. (2002). Two pathways to NF-kappaB. Mol. Cell 10, 693-695.
33. Pyrzynska, B., Pilecka, I. and Miaczynska, M. (2009). Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Mol. Oncol. 3, 321-338.
34. Qing, G., Qu, Z. and Xiao, G. (2005). Stabilization of basally translated NF-kappaBinducing kinase (NIK) protein functions as a molecular switch of processing of NFkappaB2 p100. J. Biol. Chem. 280, 40578-40582.
35. Rashid, S., Pilecka, I., Torun, A., Olchowik, M., Bielinska, B. and Miaczynska, M. (2009). Endosomal adaptor proteins APPL1 and APPL2 are novel activators of betacatenin/ TCF-mediated transcription. J. Biol. Chem. 284, 18115-18128.
36. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N. et al. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178.
37. Ruan, H., Pownall, H. J. and Lodish, H. F. (2003). Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J. Biol. Chem. 278, 28181-28192.
38. Saito, T., Jones, C. C., Huang, S., Czech, M. P. and Pilch, P. F. (2007). The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation. J. Biol. Chem. 282, 32280-32287.
39. Scheidereit, C. (2006). IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25, 6685-6705.
40. Schenck, A., Goto-Silva, L., Collinet, C., Rhinn, M., Giner, A., Habermann, B., Brand, M. and Zerial, M. (2008). The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133, 486-497.
41. Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S. C. et al. (2001). Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293, 1495-1499.
42. Shih, V. F., Tsui, R., Caldwell, A. and Hoffmann, A. (2011). A single NFkB system for both canonical and non-canonical signaling. Cell Res. 21, 86-102.
43. Stenmark, H., Parton, R. G., Steele-Mortimer, O., Lütcke, A., Gruenberg, J. and Zerial, M. (1994). Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 13, 1287-1296.
44. Sun, S. C. (2011). Non-canonical NF-κB signaling pathway. Cell Res. 21, 71-85.
45. Sun, S. C. and Ley, S. C. (2008). New insights into NF-kappaB regulation and function. Trends Immunol. 29, 469-478.
46. Takeuchi, M., Rothe, M., and Goeddel, D. V. (1996). Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271, 19935-19942.
47. Tan, Y., You, H., Wu, C., Altomare, D. A. and Testa, J. R. (2010). Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts. J. Biol. Chem. 285, 6377-6389.
48. Tang, C. H., Chiu, Y. C., Tan, T. W., Yang, R. S. and Fu, W. M. (2007). Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J. Immunol. 179, 5483-5492.
49. Thu, Y. M. and Richmond, A. (2010). NF-kB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev. 21, 213-226.
50. Urbanska, A., Sadowski, L., Kalaidzidis, Y. and Miaczynska, M. (2011). Biochemical characterization of APPL endosomes: the role of annexin A2 in APPL membrane recruitment. Traffic 12, 1227-1241.
51. Vallabhapurapu, S. and Karin, M. (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
52. Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. et al. (2007). IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669-681.
53. Wajant, H. and Scheurich, P. (2011). TNFR1-induced activation of the classical NFkB pathway. FEBS J. 278, 862-876.
54. Yamakami, M. and Yokosawa, H. (2004). Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1- and tumor necrosis factor-induced signaling pathways. Biol. Pharm. Bull. 27, 564-566.
55. Zarnegar, B., Yamazaki, S., He, J. Q. and Cheng, G. (2008a). Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. USA 105, 3503-3508.
56. Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W. C., Mak, T. W. et al. (2008b). Noncanonical NFkappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378.
57. Zhou, L., Deepa, S. S., Etzler, J. C., Ryu, J., Mao, X., Fang, Q., Liu, D. D., Torres, J. M., Jia, W., Lechleiter, J. D. et al. (2009). Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/ Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J. Biol. Chem. 284, 22426-22435.
58. Zhu, G., Chen, J., Liu, J., Brunzelle, J. S., Huang, B., Wakeham, N., Terzyan, S., Li, X., Rao, Z., Li, G. et al. (2007). Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5. EMBO J. 26, 3484-3493.
59. Zoncu, R., Perera, R. M., Balkin, D. M., Pirruccello, M., Toomre, D. and De Camilli, P. (2009). A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 136, 1110-1121.